https://www.consultant360.com/exclusive/empagliflozin-reduces-disease-progression-mortality-ckd
0
0
12/16/22 at 5:09pm
Organization
Consultant360.com
26 words
0
Comments
Researchers compared the efficacy of empagliflozin use and associated outcomes with placebo in individuals with chronic kidney disease.
You are the first to view
Create an account
or login to join the discussion